COMPOUND FOR THE TREATMENT OF PATIENTS WITH LEPTIN-RESISTANT OBESITY, BARDET-BIEDL SYNDROME AND OTHER CILIOPATHIES

摘要

The invention pertains to a peptide for the treatment of Bardet-Biedl syndrome and other ciliopathies, like primary ciliary dyskinesia, polycystic kidney and liver disease, nephronophthisis, Alström syndrome, Meckel-Gruber syndrome and some forms of retinal degeneration, like retinitis pigmentosa, rod-cone disease and retinal neuropathy, as well as the treatment of patients with leptin-resistant obesity.